YM-543, formerly known as ASP-543, is sodium-glucose transporter 2 (SGLT-2) inhibitor potentially for the treatment of type 2 diabetes. References: Yokono M, Tahara A, Kurosaki E, Yamajuku D, Kihara R, Imamura M, Tomiyama H, Kobayashi Y, Noda A, Shibasaki M. Pharmacological Characterization of YM543, a Newly Synthesized, Orally Active SGLT2 Selective Inhibitor. Endocr Res. 2013 Feb 1. [Epub ahead of print] PubMed PMID: 23374077.

纯度：≥98%

CAS：918802-70-7